Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (1,440,529)	$ (1,319,331)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	2,001	4,005
Amortization of intangibles	9,681	13,214
Stock based compensation	313,505	388,772
Employees paid in stock	264,953	50,000
Expense paid in stock	66,061	126,000
Unrealized gain on marketable securities	(27,890)	0
Amortization of right-of-use asset	24,466	22,579
Changes in operating assets and liabilities:
Increase in accounts receivable	(349,173)	(218,682)
Increase in inventories	(221,843)	(245,963)
Increase (decrease) in advances on contracts	(49,571)	170,475
Increase in prepaid expenses and other current assets	(345,804)	(323,558)
Increase (decrease) in accounts payable	415,974	(278,822)
Increase (decrease) in accounts payable, related party	378,807	(351,920)
Decrease in accrued expenses	(270,310)	(92,307)
Increase in accrued expenses, related party	33,532	73,280
Decrease operating right of use lease asset	(21,988)	(21,330)
Net cash used in operating activities	(1,218,128)	(2,003,588)
Cash flows from investing activities:
Purchase of furniture, fixtures, and equipment	0	(1,192)
Sale of Marketable securities	2,004,463	0
Purchase of Marketable securities	0	(4,430,384)
Net cash provided by (used in) investing activities	2,004,463	(4,431,576)
Cash flows from financing activities:
Net Proceeds exercise of warrants	51,751	0
Payments finance lease obligations	(2,478)	(2,162)
Net cash provided by (used in) financing activities	241,429	(2,162)
Net increase (decrease) in cash and cash equivalents	1,027,764	(6,437,326)
Cash and cash equivalents at beginning of period	2,977,713	8,715,279
Cash and cash equivalents at end of period	4,005,477	2,277,953
Public Offering [Member]
Cash flows from financing activities:
Net proceeds from Public Placement Offering	$ 192,156	$ 0